Increasing incidence of endotoxemia, high mortality rates, and growing awareness about complications with endotoxemia among patient pool are the major drivers for the growth of endotoxemia market. However, the inadequate and poor detection techniques in the diagnostic market of endotoxemia could hinder the growth of endotoxemia market.
The global endotoxemia market could be segmented based on type of diagnostic tests and drug type.
- Dimethyl Sulfoxide (DMSO)
- Based on diagnostic tests type,
- Analysis of Cytokines And Cortisol
- Analysis of Brain Specific Protein
- Cognitive Function Tests
- Based on drug type,
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
- Anti-endotoxic Drugs
- Polymyxin B
- Hyperimmune Plasma
- Dimethyl Sulfoxide (DMSO)
- Pentoxifylline (PTX)
- Low Molecular Weight Heparins
- Activated Protein C
- Ethyl Pyruvate
- DTO Smectite (Biosponge)
- Fluid Therapy
- Segmentation Based of regions
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/10715
Treatment of endotoxemia involves prevention of endotoxin from entering the circulation, neutralization, of endotoxin, elimination or decreasing the production of inflammatory mediators, and providing supportive care. There are two ways by which patients’ endotoxins could be neutralized. First is by the use of hyperimmune serum or plasma administered intravenously. The other method is by administrating Polymyxin B, cationic polypeptide antibiotic. NSAID’s are also most commonly used drugs for the treatment of patients with endotoxemia. DMSOs are often administered for its anti-inflammatory effects. PTX is been used for the treatment of intermittent claudication in patients with endotoxemia. Administering antibiotics is important to treat sepsis in patients with endotoxemia. Due to increasing incidence of endotoxemia, it is expected that the demand for drugs against endotoxemia will increase equally and this would ultimately fuel the endotoxemia market with significant CAGR over the forecast period.
Depending on geographic region, endotoxemia market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. European markets could dominate the global endotoxemia market followed by North America over the forecast period. South America, Asia-Pacific and rest of the world are at initiation state in development of drugs for the treatment. The reason for their dominance in these emerging markets is rapid technological advancement in healthcare products and services and increasing economic affluence in various countries across the region.
Key companies and universities operating in endotoxemia market are LG Life Sciences, Ltd., GlaxoSmithKline plc, Exponential Biotherapies, Inc., BASF SE, Dupont Danisco A/S, CoMentis, Inc., Radboud University, Medical University of Vienna, University of Pennsylvania, Penn State University, and many others.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/10715
The report covers exhaustive analysis on:
- Endotoxemia Market Segments
- Endotoxemia Market Dynamics
- Historical Actual Market Size, 2013 – 2015
- Endotoxemia Market Size & Forecast 2016 to 2022
- Endotoxemia Current Trends/Issues/Challenges
- Competition & Companies involved
- Endotoxemia Drivers and Restraints
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Persistence Market Research Pvt. Ltd
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353